압박 요법 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the compression therapy market size in 2026 is estimated at USD 4.52 billion, growing from 2025 value of USD 4.31 billion with 2031 projections showing USD 5.76 billion, growing at 4.96% CAGR over 2026-2031.

This report is Segmented by Technology (Static Compression Therapy, Dynamic Compression Therapy), Product (Compression Garments, Compression Pumps, Compression Braces), Application (Venous Leg Ulcers, Deep Vein Thrombosis Treatment, and More), End User (Hospitals, Specialty Clinics, Home Care, Others), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Compression Therapy Market Trends and Insights

Rising prevalence of venous disorders and lymphedema

Chronic venous insufficiency affects 25 million adults in the United States, creating continuous demand for compression therapy as a first-line intervention . High-pressure graduated stockings prevent post-thrombotic syndrome, and 2025 SCAI clinical guidelines strongly endorse their use for venous ulcers . This formal backing stabilizes procurement plans for hospitals and payers. Persistent therapeutic need produces predictable replacement cycles, allowing manufacturers to plan capacity and sustain the compression therapy market over the long term.

Growing geriatric population

Population aging places structural pressure on vascular health, especially in Asia-Pacific where the 65+ cohort is climbing at 4% annually. Clinical trials show 87.5% of older adults report improved quality of life with pneumatic compression devices. Medicare's 2024 lymphedema benefit removes cost barriers in the United States. Together, demographic inevitability and policy support ensure expanding uptake of compression solutions for chronic swelling and mobility limitations.

Lack of patient compliance and discomfort during use

Non-adherence remains a clinical hurdle; surveys show many patients discontinue stockings within weeks due to heat and difficulty donning. SIGVARIS counters with moisture-wicking yarns and temperature-regulating finishes that improve wearer experience. Digital companions now track usage and alert clinicians when wear time falls below prescription. As material science advances, the compliance barrier is expected to recede, tempering the negative CAGR impact.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing awareness about compression therapy benefits
2. Advancements in compression garments
3. Limited reimbursement in developing markets

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Static systems accounted for 67.74% of 2025 revenue, giving them the largest compression therapy market share among technologies. Dynamic pumps, though smaller, are charting a 5.68% CAGR as hospitals and home-care providers migrate to devices that tailor pressure cycles. The Kendall SCD SmartFlow platform delivers vascular refill detection to personalize therapy and cut session times. The compression therapy industry is experiencing a technological convergence where smart textiles interface with pneumatic controllers, signaling future hybrid solutions.

Dynamic devices earn premium pricing because clinical studies cite superior edema reduction and patient comfort. Hospital wound centers frequently adopt pneumatic sleeves following ulcer debridement, while home-care agencies lease portable pumps to chronic-swelling patients. Static wraps remain prevalent for their low cost and ease of training, ensuring they retain core demand within the compression therapy market.

Compression garments generated 52.02% of 2025 revenue, cementing their role as the most popular modality for daily use. Graduated stockings constitute the bulk of volume, although torso and arm sleeves are gaining attention among lymphedema patients. Pumps are forecast to post the highest 5.52% CAGR; Tactile Medical's Nimbl system achieved meaningful limb-volume reductions in 52-week trials. The compression therapy market size for pumps is expanding as payers approve rental reimbursement and remote monitoring assures adherence.

Braces and wraps hold discreet niches, especially within sports orthopedics. Manufacturers often bundle braces with moisture-managing fabrics to attract athletes seeking stabilization and compression in one product. As consumer literacy on prophylactic care rises, product lines diversify to include fashion-oriented compression socks, fueling incremental growth and reinforcing garments' dominance in the compression therapy market.

Geography Analysis

North America contributed 40.55% of 2025 revenue due to Medicare reimbursement, broad clinical literacy, and well-developed distributor networks. Hospitals replenish stockings every six months, supporting recurring orders that stabilize the compression therapy market. Europe follows with consistent adoption under public health systems; Germany's statutory funds reimburse two pairs of medical stockings per year, ensuring predictable volume.

Asia-Pacific is forecast for a 5.72% CAGR through 2031. Aging demographics intersect with rising diabetes prevalence, elevating venous and lymphatic complications. Urban hospitals in China now pilot smart-textile stockings, while Japanese home-care providers integrate pneumatic pumps for aged residents. These shifts attract foreign direct investment and spur local manufacturing clusters.

In South America and the Middle East & Africa, growth is tempered by limited reimbursement and import duties. Nonetheless, physician education programs and modular pumps priced for emerging markets are gradually elevating penetration. As these regions upgrade vascular-care infrastructure, the compression therapy market is expected to capture incremental volume gains.

1. Solventum
2. Essity AB (BSN medical)
3. medi
4. SIGVARIS Group
5. Tactile Systems Technology, Inc.
6. Arjo AB (ArjoHuntleigh)
7. DJO Global (Enovis Corporation)
8. Smiths Group
9. Hartmann Group
10. Julius Zorn GmbH (Juzo)
11. Gottfried Medical
12. Bio Compression Systems
13. Thuasne SAS
14. Lohmann & Rauscher
15. Cardinal Health
16. Molnlycke Health Care
17. DeRoyal Industries
18. Koya Medical
19. Hyperice
20. LIPOELASTIC

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising prevalence of venous disorders and lymphedema
  • 4.2.2 Growing geriatric population
  • 4.2.3 Increasing awareness about compression therapy benefits
  • 4.2.4 Advancements in compression garments
  • 4.2.5 Expanding use in sports and fitness recovery
  • 4.2.6 Favorable Reimbursement policies in developed markets
• 4.3 Market Restraints
  • 4.3.1 Lack of patient compliance and discomfort during use
  • 4.3.2 Limited reimbursement in developing markets
  • 4.3.3 Availability of alternative therapies
  • 4.3.4 High cost of advanced products
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Outlook
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Technology
  • 5.1.1 Static Compression Therapy
  • 5.1.2 Dynamic Compression Therapy
• 5.2 By Product
  • 5.2.1 Compression Garments
  • 5.2.2 Compression Pumps
  • 5.2.3 Compression Braces
• 5.3 By Application
  • 5.3.1 Venous Leg Ulcers
  • 5.3.2 Deep Vein Thrombosis Treatment
  • 5.3.3 Lymphedema Treatment
  • 5.3.4 Other Applications
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Specialty Clinics
  • 5.4.3 Home Care
  • 5.4.4 Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments)
  • 6.3.1 Solventum
  • 6.3.2 Essity AB (BSN medical)
  • 6.3.3 medi GmbH & Co. KG
  • 6.3.4 SIGVARIS Group
  • 6.3.5 Tactile Systems Technology, Inc.
  • 6.3.6 Arjo AB (ArjoHuntleigh)
  • 6.3.7 DJO Global (Enovis Corporation)
  • 6.3.8 Smith & Nephew plc
  • 6.3.9 Paul Hartmann AG
  • 6.3.10 Julius Zorn GmbH (Juzo)
  • 6.3.11 Gottfried Medical, Inc.
  • 6.3.12 Bio Compression Systems, Inc.
  • 6.3.13 Thuasne SAS
  • 6.3.14 Lohmann & Rauscher GmbH & Co. KG
  • 6.3.15 Cardinal Health, Inc.
  • 6.3.16 Molnlycke Health Care AB
  • 6.3.17 DeRoyal Industries, Inc.
  • 6.3.18 Koya Medical
  • 6.3.19 Hyperice
  • 6.3.20 LIPOELASTIC

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment